Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV845
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 28, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30 units. The contract ceiling value is $14,592.57, with an ultimate completion date of February 19, 2026. The award is non-set-aside and competitively awarded, with performance to be completed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a prescription medication used in the treatment of transthyretin amyloidosis, a rare genetic disorder affecting nerve and heart function.
This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that runs through December 2026. The IDC enables Amerisourcebergen to supply a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. As a major pharmaceutical distributor with extensive federal procurement experience, Amerisourcebergen Drug Corp demonstrates the capability to fulfill specialized medical supply requirements across multiple therapeutic domains through its established DLA relationship.
Quick answers
Who was awarded contract SPE2DR26FV845?
SPE2DR26FV845 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV845 worth?
The government has obligated $14,593 on SPE2DR26FV845.
Is contract SPE2DR26FV845 an order under another contract?
Yes. SPE2DR26FV845 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV845 competed?
The extent of competition for SPE2DR26FV845 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award